Clinical Trials Browser

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT06070623 2023-10-06

Follow up After TACE by Elastography and Color Doppler.

Unknown

54 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06042842 2023-10-04

The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

Unknown

102 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06062706 2023-10-02

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy

Unknown

3,448 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Failure, Acute, End Stage Liver Disease, Acute-On-Chronic Liver Failure

NCT05010434 2023-09-21

Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma

Phase 2 Unknown

46 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06039280 2023-09-15

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Phase NA Unknown

150 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

HELIO

Clinical Characteristics of Primary Liver Cancer

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

OPTIMAL

ARTIHCC

EVALHEP

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

HAI-TL

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC

HCC

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Prediction

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

PREVENT-2

FAPI

Longitudinal Immune-phenotyping of HCC Following MK-3475

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

SBRT With DIBH for HCC After TACE and Lipiodol Marking

Notable-HCC

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy

A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy

CCGLC-003

CCGLC-004

CCGLC-002

CCGLC-007

TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma

PETMRIinHCC

Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.

A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.

EMERITUS-2

SARCOLIVER

A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Patient-Derived Xenografts to Reduce Cancer Health Disparities

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

CAT_PB

Follow up After TACE by Elastography and Color Doppler.

The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy

Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.